F. Recchia
University of Padua · 564 works · 7,706 citations · h-index 42
Top works
- AGATA—Advanced GAmma Tracking Array
- Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study
- The large enriched germanium experiment for neutrinoless double beta decay (LEGEND)
- Gonadotropin‐releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma
- Conceptual design and infrastructure for the installation of the first AGATA sub-array at LNL
- Evidence for a spin-aligned neutron–proton paired phase from the level structure of 92Pd
- Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study
- Conceptual design and Monte Carlo simulations of the AGATA array
- Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)
- Spectroscopy of neutron-rich Fe isotopes populated in the Ni64 + U238 reaction
- Multinucleon transfer reactions in closed-shell nuclei
- Onset of collectivity in neutron-rich Fe isotopes: Toward a new island of inversion?
- Malignant Metastatic Eccrine Poroma
- Randomized Trial of 5-Fluorouracil and High-Dose Folinic Acid With or Without Alpha-2B Interferon in Advanced Colorectal Cancer
- Lifetime Measurements of the Neutron-Rich N = 30 Isotones Ca 50 and Sc 51 : Orbital Dependence of Effective Charges in the f p Shell
- Spectroscopy of neutron-rich Mn59−63 isotopes
- Position resolution of the prototype AGATA triple-cluster detector from an in-beam experiment
- Spectroscopy of odd-mass cobalt isotopes toward the N=40 subshell closure and shell-model description of spherical and deformed states
- Interaction position resolution simulations and in-beam measurements of the AGATA HPGe detectors
- ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin